Trump's 'common sense' overhaul of marijuana rules could boost budding industry. But investors should be on high alert

Core Viewpoint - President Trump signed an executive order to reclassify marijuana from Schedule I to Schedule III, facilitating medical research and potentially impacting the cannabis industry positively [1][2][3] Group 1: Reclassification Impact - The reclassification allows for easier federally approved research on marijuana, which could lead to new medical applications and market opportunities [5] - Cannabis businesses may gain access to federal tax deductions, unlocking significant tax savings and research opportunities [4] Group 2: Medical Research and Economic Effects - The order emphasizes the potential of marijuana as a substitute for opioid painkillers, highlighting its legitimate medical applications [3] - The reclassification is expected to have immediate economic effects, creating new investment opportunities while also presenting risks [4]